With data from one of the most extensive genomic surveys of the syphilis bacterium – correlated with clinical information from patients – an international team of researchers and doctors are on the hunt for proteins on the surface of the microbe that don’t vary and could be good targets for a much-needed vaccine. At the … Read more

Jonathan Parr, MD, MPH, assistant professor medicine and researcher with the Institute for Global Health and Infectious Diseases, has been elected to the American Society for Clinical Investigation (ASCI), a nonprofit medical honor society that seeks to seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve the health of … Read more

Post-doctoral fellow Ashenafi Assefa, PhD, and Jonathan Parr, MD, MPH, assistant professor of medicine in infectious diseases, researchers with the Institute for Global Health and Infectious Diseases (IGHID) working in the IDEEL (the Infectious Disease Epidemiology and Ecology) Lab assess the pros and cons of a new strategy to simplify malaria treatment, both published today in … Read more

Researchers in the Infectious Disease Epidemiology and Ecology Lab (IDEEL) at UNC are process driven investigators with a unique comradery, working in 20+ countries to improve basic understandings of pathogens. The applied nature of their work has a direct impact on the health and well-being of millions of individuals around the globe, while also having … Read more

Researchers with the Institute for Global Health and Infectious Diseases (IGHID) through IDEEL (the Infectious Disease Epidemiology and Ecology Lab), have detected new strains of malaria-causing parasites in Ethiopia that are both resistant to current treatments and escape detection by common diagnostic tests. Jonathan Parr, MD, MPH, IGHID member and assistant professor of medicine in … Read more

UNC School of Medicine’s Institute for Global Health & Infectious Diseases has been awarded a $2.9 million grant from the Bill & Melinda Gates Foundation to establish malaria genomic surveillance capacity in the Democratic Republic of Congo (DRC).  Dr. Jonathan Parr is the lead PI, with Dr. Jon Juliano and researchers in the Infectious Disease … Read more

  In the first COVID-19 case series of tocilizumab in the United States, UNC-Chapel Hill researchers report sobering results. They say the drug should be used judiciously until randomized clinical trials determine tocilizumab’s true efficacy. Meanwhile, medical students sidelined from clinical rotations by the virus conducted the research with lightning speed, all virtually. In the … Read more